Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Priority Review Vouchers, FDA Funding Win In Omnibus Budget Deal

This article was originally published in The Pink Sheet Daily

Executive Summary

FY 2016 funding bill is much higher than House and Senate appropriations committee totals.

You may also be interested in...

US FDA Gains Budget Increase In FY 2017… And Not Through Fees

Omnibus legislation to fund the federal government for FY 2017 includes an increase in non-user fee funds, which should please stakeholders.

Pediatric Rare Disease Voucher Program Faces Expiration

Stakeholders push Congress to renew program, although 21st Century Cures route unlikely.

Electronic Labeling Study By GAO Yields “No Consensus,” Avoids Cost Issue

In study mandated by FDASIA, GAO says there are advantages and disadvantages to switching to an electronic-only system for distributing drug label information, but offers no conclusions.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts